OneMedNet Form 4 Shows Director Yu Jeffrey Buys 903,614 Shares At $0.83/Share; Director Kosasa Thomas Buys 595,238 Shares At $0.84/Share
OneMedNet Announces RWD Revenue Increased 329% YoY, Rising From $292,000 In 2024 To $1,254,000 In 2025
OneMedNet Collaborates With Inka Health To Provide Access To U.S. Real‑World Oncology Data Via iRWD Platform Powered By Palantir Foundry
OneMedNet Partners With Navidence Over Precision Real-World Data Insights
What's Going On With Penny Stock OneMedNet On Tuesday?
OneMedNet shares are trading higher after the company announced the next phase of commercial launch with its RWD Platform powered by Palantir Foundry.
OneMedNet Stock Skyrockets As It Rolls Out Next RWD Phase With Palantir Foundry
OneMedNet Announces Next Phase Of Commercial Rollout With Its Palantir Foundry-Powered RWD Platform
OneMedNet Partners With ViuHealth To Expand Autoimmune Clinical Ontology On iRWD Platform Powered By Palantir Foundry
OneMedNet Announces Strategic Neuro Data Partnership with Risorius to Advance EEG-Based Digital Biomarkers
OneMedNet Signs Licensing Deal With Risorius To Expands Its Base Of Subscription Contracts
OneMedNet shares are trading higher after the company reported year-over-year increase in 2025 bookings.
OneMedNet Reports Record 2025 Bookings of $2.79 Million, Surpassing Prior Year by More Than 4.1X and Accelerating Subscription Transition
OneMedNet Reports Record Bookings Of $2,79M In 2025, 410% Increase Y/Y
OneMedNet Real-World Data Supports FDA 510(k) Clearance of AI-Powered Scaida BrainCT-ICH Software
OneMedNet Says Its Multimodal Clinical Data Supports mlHealth 360 In Obtaining FDA 510(K) Clearance For Scaida BrainCT-ICH Software
OneMedNet Delivers a Real-World Data feed of 1.5M Patients consisting of 4M encounters
OneMedNet CEO Letter Says The Company Plans To Leverage Palantir's AI Platform To Accelerate The Development Of Its Regulatory-Grade, AI-Ready Real-World Data Network
OneMedNet Corp shares are trading higher after recent form4 fillings showed multiple insider transactions.
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.